BPC-157

What is BPC-157?

BPC-157 (Body Protection Compound-157) is a synthetic peptide made up of 15 amino acids. Its sequence is derived from a protein found naturally in human gastric juice, where the parent compound is thought to contribute to the stomach lining's remarkable ability to protect and repair itself.

In research and clinical settings, BPC-157 is studied as a body-wide healing agent. Unlike growth-hormone peptides, it has no direct hormonal or androgenic activity — it works locally on tissue-repair and vascular pathways. It is not an FDA-approved drug; in the United States it is prescribed only as a pharmacy-compounded preparation under physician supervision.

How BPC-157 works

BPC-157's best-characterized action is angiogenesis — promoting the formation of new blood vessels at an injury site. Better blood supply delivers oxygen, nutrients, and repair cells to damaged tendon, ligament, and muscle, which are otherwise slow to heal because of their limited native blood flow.

Preclinical work also points to upregulation of growth-factor receptors (notably the VEGFR2 pathway), modulation of nitric-oxide signaling, and effects on fibroblast migration and collagen organization. Together these mechanisms are proposed to accelerate the remodeling phase of healing and to exert a protective, anti-inflammatory effect on the gut lining.

What BPC-157 is used for

What the evidence shows

The great majority of BPC-157 evidence comes from animal models, where results have been consistent and striking: accelerated healing of transected Achilles tendon, medial collateral ligament, and muscle, plus protection of the gastrointestinal tract against a range of insults [1][2].

Mechanistic studies attribute these effects to angiogenesis and growth-factor upregulation at the injury site [2][3]. What is missing is high-quality human data: as of this writing there are no large, published randomized controlled trials in people, so BPC-157 sits in the category of a promising compound with strong preclinical support and limited clinical validation.

We present this honestly to every patient. BPC-157 is used in clinical practice on the strength of its safety profile and mechanistic rationale, not on the basis of definitive human efficacy trials — and that distinction matters when you are deciding whether it fits your goals.

Dosing & administration context

BPC-157 is most often administered by subcutaneous injection near the area of injury, though oral and other routes have been studied. Protocols in clinical use are typically short courses measured in weeks, with the dose expressed in micrograms per kilogram of body weight.

The specific dose, route, frequency, and duration are individualized by the prescribing physician based on the injury, your body weight, and your response — which is why we frame this as clinical context, not a self-dosing guide. BPC-157 obtained without a prescription (research-only vials, gray-market powders) carries no guarantee of identity, purity, or sterility.

BPC-157 is not an FDA-approved medication. Content on this page is clinical context for physician-supervised, pharmacy-compounded use — not a dosing guide or a substitute for medical advice.

Safety & side effects

Across preclinical studies BPC-157 has shown a wide safety margin, with no consistent pattern of serious toxicity even at high doses. Reported effects in clinical use are generally mild and self-limiting.

Because human safety data are limited, we screen carefully before prescribing and monitor throughout a course. The most important safety principle is source control — a pharmacy-compounded product from a licensed 503A/503B pharmacy is a fundamentally different risk profile than a research vial of unknown origin.

How Strong Health prescribes BPC-157

At Strong Health, BPC-157 is prescribed only after an in-person or telehealth physician evaluation, a review of your injury history, and — where relevant — labs. It is dispensed exclusively through licensed 503A or 503B compounding pharmacies under physician orders; we do not sell or recommend research-only product.

We treat BPC-157 as one component of a recovery plan, not a standalone fix. For tendon and ligament injuries it is frequently combined with TB-500 and paired with appropriate rehabilitation. Your physician sets the protocol, reviews your response at scheduled intervals, and adjusts or stops treatment based on how you actually heal.

Available in person at our Miami (Brickell) clinic and via telehealth across our service areas.

Frequently asked questions